达拉图马布加上博尔特佐米布和德克萨米松作为桥梁,用于在耐火T细胞淋巴细胞淋巴瘤中进行全基移植
Alessio Maria Edoardo Maraglino1, Simona Sammassimo1, Ginevra Lolli1
1European Institute of Oncology, Milan, Italy.
Annals of hematology
|June 26, 2025
概括
达拉图马布与博尔特佐米布和德克萨米结合,为复发性T细胞淋巴细胞淋巴瘤提供了新的希望. 这种救援疗法使得在一个对多次先前治疗不耐药的患者中持续缓解.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 复发性和耐火性 (r/r) T 细胞淋巴细胞淋巴瘤 (T-LBL) 是一个重要的治疗挑战,有效的选择有限.
- CD38阳性T-LBL是一种侵略性的亚型,需要新的治疗策略.
关键词:
全基性造血干细胞移植,Allo-HSCT达拉 - 博尔 - 德克斯,达拉图穆马布 - 博尔特佐米布 - 德克萨梅他.在T-ALL,T-淋巴细胞急性白血病中.这是T-LBL,T细胞淋巴细胞淋巴瘤.r/r,复发性和耐火性的更多相关视频
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
8.0K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.4K
相关概念视频
Bone Marrow Sampling and Transplants
491
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
491
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)